Detalles de la búsqueda
1.
In vitro and in vivo activity of R547: a potent and selective cyclin-dependent kinase inhibitor currently in phase I clinical trials.
Mol Cancer Ther
; 5(11): 2644-58, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-17121911
2.
Pharmacokinetics, safety, and tolerability of R411, a dual alpha4beta1-alpha4beta7 integrin antagonist after oral administration at single and multiple once-daily ascending doses in healthy volunteers.
J Clin Pharmacol
; 44(12): 1368-78, 2004 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-15545307
Resultados
1 -
2
de 2
1
Próxima >
>>